nodes	percent_of_prediction	percent_of_DWPC	metapath
Abacavir—Nelarabine—hematologic cancer	0.256	0.582	CrCtD
Abacavir—Cladribine—hematologic cancer	0.184	0.418	CrCtD
Abacavir—UGT1A1—hematologic cancer	0.155	1	CbGaD
Abacavir—Cladribine—Pentostatin—hematologic cancer	0.0373	0.155	CrCrCtD
Abacavir—Nelarabine—Clofarabine—hematologic cancer	0.037	0.154	CrCrCtD
Abacavir—Cladribine—Clofarabine—hematologic cancer	0.0332	0.138	CrCrCtD
Abacavir—Cladribine—Nelarabine—hematologic cancer	0.0313	0.13	CrCrCtD
Abacavir—Nelarabine—Fludarabine—hematologic cancer	0.0271	0.113	CrCrCtD
Abacavir—UGT1A1—Nilotinib—hematologic cancer	0.0271	0.447	CbGbCtD
Abacavir—Nelarabine—Cytarabine—hematologic cancer	0.0256	0.106	CrCrCtD
Abacavir—Nelarabine—Cladribine—hematologic cancer	0.025	0.104	CrCrCtD
Abacavir—Cladribine—Fludarabine—hematologic cancer	0.0244	0.101	CrCrCtD
Abacavir—UGT1A1—Irinotecan—hematologic cancer	0.0186	0.307	CbGbCtD
Abacavir—UGT1A1—Etoposide—hematologic cancer	0.0149	0.246	CbGbCtD
Abacavir—ADK—Purine salvage—DCK—hematologic cancer	0.00239	0.136	CbGpPWpGaD
Abacavir—ADH6—lung—hematologic cancer	0.00215	0.287	CbGeAlD
Abacavir—ADK—Purine metabolism—GMPS—hematologic cancer	0.00142	0.0808	CbGpPWpGaD
Abacavir—ADK—Purine metabolism—DCK—hematologic cancer	0.00114	0.0646	CbGpPWpGaD
Abacavir—ADK—hematopoietic system—hematologic cancer	0.000857	0.114	CbGeAlD
Abacavir—UGT1A1—hematopoietic system—hematologic cancer	0.000845	0.113	CbGeAlD
Abacavir—Nelarabine—DCK—hematologic cancer	0.000768	0.536	CrCbGaD
Abacavir—ADK—Nucleotide metabolism—GMPS—hematologic cancer	0.000714	0.0406	CbGpPWpGaD
Abacavir—ADK—gonad—hematologic cancer	0.000651	0.087	CbGeAlD
Abacavir—ADK—Nucleotide metabolism—DCK—hematologic cancer	0.000571	0.0325	CbGpPWpGaD
Abacavir—ADK—blood—hematologic cancer	0.000568	0.0758	CbGeAlD
Abacavir—UGT1A1—blood—hematologic cancer	0.00056	0.0748	CbGeAlD
Abacavir—ADK—bone marrow—hematologic cancer	0.000549	0.0734	CbGeAlD
Abacavir—UGT1A1—Codeine and Morphine Metabolism—ABCC3—hematologic cancer	0.000543	0.0308	CbGpPWpGaD
Abacavir—ADK—lung—hematologic cancer	0.000498	0.0665	CbGeAlD
Abacavir—ADK—Nucleotide metabolism—CDA—hematologic cancer	0.000495	0.0281	CbGpPWpGaD
Abacavir—ADK—testis—hematologic cancer	0.000469	0.0627	CbGeAlD
Abacavir—ADH6—Biological oxidations—SLC35B2—hematologic cancer	0.000458	0.026	CbGpPWpGaD
Abacavir—Cladribine—DCK—hematologic cancer	0.000429	0.3	CrCbGaD
Abacavir—ADK—lymph node—hematologic cancer	0.00034	0.0455	CbGeAlD
Abacavir—ADK—Nucleotide metabolism—TXN—hematologic cancer	0.000297	0.0169	CbGpPWpGaD
Abacavir—ADH6—Biological oxidations—GSTO1—hematologic cancer	0.000295	0.0168	CbGpPWpGaD
Abacavir—UGT1A1—Irinotecan Pathway—ABCG2—hematologic cancer	0.000283	0.0161	CbGpPWpGaD
Abacavir—ADH6—Biological oxidations—UGT1A1—hematologic cancer	0.000277	0.0158	CbGpPWpGaD
Abacavir—UGT1A1—Codeine and Morphine Metabolism—ABCB1—hematologic cancer	0.000276	0.0157	CbGpPWpGaD
Abacavir—ADH6—Biological oxidations—MTR—hematologic cancer	0.000241	0.0137	CbGpPWpGaD
Abacavir—ADH6—Biological oxidations—GSTT1—hematologic cancer	0.000229	0.013	CbGpPWpGaD
Abacavir—UGT1A1—Estrogen metabolism—NQO1—hematologic cancer	0.000183	0.0104	CbGpPWpGaD
Abacavir—UGT1A1—Constitutive Androstane Receptor Pathway—ABCC3—hematologic cancer	0.000179	0.0102	CbGpPWpGaD
Abacavir—ADH6—Biological oxidations—GSTP1—hematologic cancer	0.000159	0.00902	CbGpPWpGaD
Abacavir—ADH6—Biological oxidations—GSTM1—hematologic cancer	0.000146	0.00828	CbGpPWpGaD
Abacavir—UGT1A1—Estrogen metabolism—GSTM1—hematologic cancer	0.00014	0.00796	CbGpPWpGaD
Abacavir—Cladribine—SLC22A1—hematologic cancer	0.000138	0.0967	CrCbGaD
Abacavir—UGT1A1—Constitutive Androstane Receptor Pathway—SMC1A—hematologic cancer	0.000131	0.00747	CbGpPWpGaD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—JUND—hematologic cancer	0.000126	0.00716	CbGpPWpGaD
Abacavir—UGT1A1—Phase II conjugation—SLC35B2—hematologic cancer	0.000124	0.00703	CbGpPWpGaD
Abacavir—ADH6—Metabolism—FTCD—hematologic cancer	0.000122	0.00691	CbGpPWpGaD
Abacavir—ADH6—Metabolism—GMPS—hematologic cancer	0.000122	0.00691	CbGpPWpGaD
Abacavir—ADH6—Metabolism—PHYH—hematologic cancer	0.000122	0.00691	CbGpPWpGaD
Abacavir—ADH6—Metabolism—SMPD3—hematologic cancer	0.000111	0.00632	CbGpPWpGaD
Abacavir—UGT1A1—Constitutive Androstane Receptor Pathway—HSP90AA1—hematologic cancer	0.000108	0.00617	CbGpPWpGaD
Abacavir—ADH6—Metabolism—B3GAT1—hematologic cancer	9.71e-05	0.00552	CbGpPWpGaD
Abacavir—ADH6—Metabolism—DCK—hematologic cancer	9.71e-05	0.00552	CbGpPWpGaD
Abacavir—ADH6—Metabolism—ASNS—hematologic cancer	9.71e-05	0.00552	CbGpPWpGaD
Abacavir—Cladribine—ABCG2—hematologic cancer	9.67e-05	0.0675	CrCbGaD
Abacavir—ADH6—Metabolism—HDC—hematologic cancer	9.21e-05	0.00524	CbGpPWpGaD
Abacavir—UGT1A1—Constitutive Androstane Receptor Pathway—ABCB1—hematologic cancer	9.11e-05	0.00518	CbGpPWpGaD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—NQO1—hematologic cancer	8.63e-05	0.0049	CbGpPWpGaD
Abacavir—UGT1A1—Constitutive Androstane Receptor Pathway—FOXO1—hematologic cancer	8.62e-05	0.0049	CbGpPWpGaD
Abacavir—ADH6—Metabolism—CDA—hematologic cancer	8.42e-05	0.00479	CbGpPWpGaD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—HSP90AA1—hematologic cancer	8.11e-05	0.00461	CbGpPWpGaD
Abacavir—ADH6—Metabolism—PC—hematologic cancer	8.11e-05	0.00461	CbGpPWpGaD
Abacavir—UGT1A1—Phase II conjugation—GSTO1—hematologic cancer	7.97e-05	0.00453	CbGpPWpGaD
Abacavir—ADH6—Metabolism—GBA—hematologic cancer	7.83e-05	0.00445	CbGpPWpGaD
Abacavir—ADH6—Metabolism—SLC35B2—hematologic cancer	7.83e-05	0.00445	CbGpPWpGaD
Abacavir—UGT1A1—Biological oxidations—SLC35B2—hematologic cancer	7.23e-05	0.00411	CbGpPWpGaD
Abacavir—ADH6—Metabolism—MTAP—hematologic cancer	7.16e-05	0.00407	CbGpPWpGaD
Abacavir—UGT1A1—Metapathway biotransformation—EPHX1—hematologic cancer	7.13e-05	0.00406	CbGpPWpGaD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—HES1—hematologic cancer	6.65e-05	0.00378	CbGpPWpGaD
Abacavir—UGT1A1—Phase II conjugation—MTR—hematologic cancer	6.5e-05	0.00369	CbGpPWpGaD
Abacavir—ADK—Metabolism—GMPS—hematologic cancer	6.49e-05	0.00369	CbGpPWpGaD
Abacavir—ADK—Metabolism—PHYH—hematologic cancer	6.49e-05	0.00369	CbGpPWpGaD
Abacavir—ADK—Metabolism—FTCD—hematologic cancer	6.49e-05	0.00369	CbGpPWpGaD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—BAX—hematologic cancer	6.44e-05	0.00366	CbGpPWpGaD
Abacavir—ADH6—Metabolism—FHL2—hematologic cancer	6.38e-05	0.00363	CbGpPWpGaD
Abacavir—ADH6—Metabolism—AGRN—hematologic cancer	6.26e-05	0.00356	CbGpPWpGaD
Abacavir—UGT1A1—Phase II conjugation—GSTT1—hematologic cancer	6.18e-05	0.00351	CbGpPWpGaD
Abacavir—ADK—Metabolism—SMPD3—hematologic cancer	5.93e-05	0.00337	CbGpPWpGaD
Abacavir—ADH6—Metabolism—HMMR—hematologic cancer	5.93e-05	0.00337	CbGpPWpGaD
Abacavir—ADH6—Metabolism—IDH2—hematologic cancer	5.93e-05	0.00337	CbGpPWpGaD
Abacavir—ADH6—Metabolism—ARNTL—hematologic cancer	5.58e-05	0.00317	CbGpPWpGaD
Abacavir—ADH6—Metabolism—CA9—hematologic cancer	5.43e-05	0.00309	CbGpPWpGaD
Abacavir—ADH6—Metabolism—ACP5—hematologic cancer	5.43e-05	0.00309	CbGpPWpGaD
Abacavir—ADH6—Metabolism—NCOR2—hematologic cancer	5.36e-05	0.00305	CbGpPWpGaD
Abacavir—UGT1A1—NRF2 pathway—TXN—hematologic cancer	5.31e-05	0.00302	CbGpPWpGaD
Abacavir—UGT1A1—NRF2 pathway—ABCC3—hematologic cancer	5.31e-05	0.00302	CbGpPWpGaD
Abacavir—ADK—Metabolism—B3GAT1—hematologic cancer	5.19e-05	0.00295	CbGpPWpGaD
Abacavir—ADK—Metabolism—DCK—hematologic cancer	5.19e-05	0.00295	CbGpPWpGaD
Abacavir—ADK—Metabolism—ASNS—hematologic cancer	5.19e-05	0.00295	CbGpPWpGaD
Abacavir—ADH6—Metabolism—IDH1—hematologic cancer	5.1e-05	0.0029	CbGpPWpGaD
Abacavir—ADH6—Metabolism—GSTO1—hematologic cancer	5.05e-05	0.00287	CbGpPWpGaD
Abacavir—ADH6—Metabolism—TXN—hematologic cancer	5.05e-05	0.00287	CbGpPWpGaD
Abacavir—ADH6—Metabolism—ABCC3—hematologic cancer	5.05e-05	0.00287	CbGpPWpGaD
Abacavir—ADH6—Metabolism—SPHK1—hematologic cancer	4.94e-05	0.00281	CbGpPWpGaD
Abacavir—ADK—Metabolism—HDC—hematologic cancer	4.92e-05	0.0028	CbGpPWpGaD
Abacavir—ADH6—Metabolism—UGT1A1—hematologic cancer	4.74e-05	0.0027	CbGpPWpGaD
Abacavir—UGT1A1—Biological oxidations—GSTO1—hematologic cancer	4.66e-05	0.00265	CbGpPWpGaD
Abacavir—ADH6—Metabolism—SLC22A1—hematologic cancer	4.62e-05	0.00262	CbGpPWpGaD
Abacavir—ADH6—Metabolism—CRABP1—hematologic cancer	4.62e-05	0.00262	CbGpPWpGaD
Abacavir—UGT1A1—Metapathway biotransformation—GSTO1—hematologic cancer	4.6e-05	0.00261	CbGpPWpGaD
Abacavir—ADH6—Metabolism—ALOX5—hematologic cancer	4.5e-05	0.00256	CbGpPWpGaD
Abacavir—ADK—Metabolism—CDA—hematologic cancer	4.5e-05	0.00256	CbGpPWpGaD
Abacavir—ADH6—Metabolism—NUP98—hematologic cancer	4.36e-05	0.00248	CbGpPWpGaD
Abacavir—ADK—Metabolism—PC—hematologic cancer	4.33e-05	0.00246	CbGpPWpGaD
Abacavir—UGT1A1—Phase II conjugation—GSTP1—hematologic cancer	4.28e-05	0.00243	CbGpPWpGaD
Abacavir—ADH6—Metabolism—ADCY7—hematologic cancer	4.23e-05	0.0024	CbGpPWpGaD
Abacavir—ADH6—Metabolism—NCOA3—hematologic cancer	4.23e-05	0.0024	CbGpPWpGaD
Abacavir—ADH6—Metabolism—NUP214—hematologic cancer	4.2e-05	0.00239	CbGpPWpGaD
Abacavir—ADK—Metabolism—GBA—hematologic cancer	4.18e-05	0.00238	CbGpPWpGaD
Abacavir—ADK—Metabolism—SLC35B2—hematologic cancer	4.18e-05	0.00238	CbGpPWpGaD
Abacavir—ADH6—Metabolism—ABCG2—hematologic cancer	4.11e-05	0.00234	CbGpPWpGaD
Abacavir—ADH6—Metabolism—MTR—hematologic cancer	4.11e-05	0.00234	CbGpPWpGaD
Abacavir—ADH6—Metabolism—ENO2—hematologic cancer	4.03e-05	0.00229	CbGpPWpGaD
Abacavir—UGT1A1—Phase II conjugation—GSTM1—hematologic cancer	3.94e-05	0.00224	CbGpPWpGaD
Abacavir—ADH6—Metabolism—GSTT1—hematologic cancer	3.91e-05	0.00222	CbGpPWpGaD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—hematologic cancer	3.89e-05	0.00221	CbGpPWpGaD
Abacavir—ADH6—Metabolism—SDC1—hematologic cancer	3.82e-05	0.00217	CbGpPWpGaD
Abacavir—ADK—Metabolism—MTAP—hematologic cancer	3.82e-05	0.00217	CbGpPWpGaD
Abacavir—UGT1A1—Biological oxidations—MTR—hematologic cancer	3.8e-05	0.00216	CbGpPWpGaD
Abacavir—UGT1A1—Biological oxidations—GSTT1—hematologic cancer	3.61e-05	0.00205	CbGpPWpGaD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—hematologic cancer	3.53e-05	0.00201	CbGpPWpGaD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—hematologic cancer	3.47e-05	0.00197	CbGpPWpGaD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL2—hematologic cancer	3.46e-05	0.00196	CbGpPWpGaD
Abacavir—UGT1A1—NRF2 pathway—NQO1—hematologic cancer	3.42e-05	0.00195	CbGpPWpGaD
Abacavir—ADK—Metabolism—FHL2—hematologic cancer	3.41e-05	0.00194	CbGpPWpGaD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—JUN—hematologic cancer	3.36e-05	0.00191	CbGpPWpGaD
Abacavir—ADK—Metabolism—AGRN—hematologic cancer	3.34e-05	0.0019	CbGpPWpGaD
Abacavir—ADH6—Metabolism—CD44—hematologic cancer	3.25e-05	0.00185	CbGpPWpGaD
Abacavir—ADH6—Metabolism—NQO1—hematologic cancer	3.25e-05	0.00185	CbGpPWpGaD
Abacavir—UGT1A1—NRF2 pathway—HSP90AA1—hematologic cancer	3.22e-05	0.00183	CbGpPWpGaD
Abacavir—ADK—Metabolism—HMMR—hematologic cancer	3.17e-05	0.0018	CbGpPWpGaD
Abacavir—ADK—Metabolism—IDH2—hematologic cancer	3.17e-05	0.0018	CbGpPWpGaD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EP300—hematologic cancer	3.1e-05	0.00176	CbGpPWpGaD
Abacavir—ADH6—Metabolism—CYCS—hematologic cancer	3.08e-05	0.00175	CbGpPWpGaD
Abacavir—ADH6—Metabolism—HSP90AA1—hematologic cancer	3.06e-05	0.00174	CbGpPWpGaD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—SRC—hematologic cancer	3.02e-05	0.00171	CbGpPWpGaD
Abacavir—ADK—Metabolism—ARNTL—hematologic cancer	2.98e-05	0.00169	CbGpPWpGaD
Abacavir—ADK—Metabolism—ACP5—hematologic cancer	2.9e-05	0.00165	CbGpPWpGaD
Abacavir—ADK—Metabolism—CA9—hematologic cancer	2.9e-05	0.00165	CbGpPWpGaD
Abacavir—ADK—Metabolism—NCOR2—hematologic cancer	2.86e-05	0.00163	CbGpPWpGaD
Abacavir—UGT1A1—NRF2 pathway—GSTP1—hematologic cancer	2.86e-05	0.00162	CbGpPWpGaD
Abacavir—ADK—Metabolism—IDH1—hematologic cancer	2.72e-05	0.00155	CbGpPWpGaD
Abacavir—ADH6—Metabolism—GSTP1—hematologic cancer	2.71e-05	0.00154	CbGpPWpGaD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—hematologic cancer	2.7e-05	0.00153	CbGpPWpGaD
Abacavir—ADK—Metabolism—ABCC3—hematologic cancer	2.69e-05	0.00153	CbGpPWpGaD
Abacavir—ADK—Metabolism—GSTO1—hematologic cancer	2.69e-05	0.00153	CbGpPWpGaD
Abacavir—ADK—Metabolism—TXN—hematologic cancer	2.69e-05	0.00153	CbGpPWpGaD
Abacavir—ADK—Metabolism—SPHK1—hematologic cancer	2.64e-05	0.0015	CbGpPWpGaD
Abacavir—UGT1A1—NRF2 pathway—GSTM1—hematologic cancer	2.62e-05	0.00149	CbGpPWpGaD
Abacavir—UGT1A1—NRF2 pathway—HGF—hematologic cancer	2.62e-05	0.00149	CbGpPWpGaD
Abacavir—ADH6—Metabolism—ABCB1—hematologic cancer	2.57e-05	0.00146	CbGpPWpGaD
Abacavir—ADK—Metabolism—UGT1A1—hematologic cancer	2.53e-05	0.00144	CbGpPWpGaD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—hematologic cancer	2.52e-05	0.00143	CbGpPWpGaD
Abacavir—UGT1A1—Biological oxidations—GSTP1—hematologic cancer	2.51e-05	0.00142	CbGpPWpGaD
Abacavir—ADH6—Metabolism—NCOR1—hematologic cancer	2.49e-05	0.00142	CbGpPWpGaD
Abacavir—ADH6—Metabolism—GSTM1—hematologic cancer	2.49e-05	0.00142	CbGpPWpGaD
Abacavir—UGT1A1—Metapathway biotransformation—GSTP1—hematologic cancer	2.47e-05	0.0014	CbGpPWpGaD
Abacavir—ADK—Metabolism—SLC22A1—hematologic cancer	2.46e-05	0.0014	CbGpPWpGaD
Abacavir—ADK—Metabolism—CRABP1—hematologic cancer	2.46e-05	0.0014	CbGpPWpGaD
Abacavir—ADK—Metabolism—ALOX5—hematologic cancer	2.4e-05	0.00137	CbGpPWpGaD
Abacavir—ADK—Metabolism—NUP98—hematologic cancer	2.33e-05	0.00132	CbGpPWpGaD
Abacavir—UGT1A1—Biological oxidations—GSTM1—hematologic cancer	2.3e-05	0.00131	CbGpPWpGaD
Abacavir—UGT1A1—Metapathway biotransformation—GSTM1—hematologic cancer	2.27e-05	0.00129	CbGpPWpGaD
Abacavir—UGT1A1—NRF2 pathway—PDGFB—hematologic cancer	2.26e-05	0.00128	CbGpPWpGaD
Abacavir—ADK—Metabolism—ADCY7—hematologic cancer	2.26e-05	0.00128	CbGpPWpGaD
Abacavir—ADK—Metabolism—NCOA3—hematologic cancer	2.26e-05	0.00128	CbGpPWpGaD
Abacavir—ADK—Metabolism—NUP214—hematologic cancer	2.24e-05	0.00127	CbGpPWpGaD
Abacavir—ADH6—Metabolism—MTHFR—hematologic cancer	2.2e-05	0.00125	CbGpPWpGaD
Abacavir—ADK—Metabolism—MTR—hematologic cancer	2.2e-05	0.00125	CbGpPWpGaD
Abacavir—ADK—Metabolism—ABCG2—hematologic cancer	2.2e-05	0.00125	CbGpPWpGaD
Abacavir—ADK—Metabolism—ENO2—hematologic cancer	2.15e-05	0.00122	CbGpPWpGaD
Abacavir—ADK—Metabolism—GSTT1—hematologic cancer	2.09e-05	0.00119	CbGpPWpGaD
Abacavir—ADK—Metabolism—SDC1—hematologic cancer	2.04e-05	0.00116	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—PHYH—hematologic cancer	1.92e-05	0.00109	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—FTCD—hematologic cancer	1.92e-05	0.00109	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—GMPS—hematologic cancer	1.92e-05	0.00109	CbGpPWpGaD
Abacavir—ADH6—Metabolism—PIK3CG—hematologic cancer	1.85e-05	0.00105	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—SMPD3—hematologic cancer	1.76e-05	0.000998	CbGpPWpGaD
Abacavir—ADK—Metabolism—NQO1—hematologic cancer	1.74e-05	0.000987	CbGpPWpGaD
Abacavir—ADK—Metabolism—CD44—hematologic cancer	1.74e-05	0.000987	CbGpPWpGaD
Abacavir—ADH6—Metabolism—CREBBP—hematologic cancer	1.72e-05	0.000975	CbGpPWpGaD
Abacavir—ADK—Metabolism—CYCS—hematologic cancer	1.64e-05	0.000934	CbGpPWpGaD
Abacavir—ADK—Metabolism—HSP90AA1—hematologic cancer	1.63e-05	0.000928	CbGpPWpGaD
Abacavir—ADH6—Metabolism—PIK3CD—hematologic cancer	1.63e-05	0.000925	CbGpPWpGaD
Abacavir—ADH6—Metabolism—ALB—hematologic cancer	1.61e-05	0.000913	CbGpPWpGaD
Abacavir—ADH6—Metabolism—PIK3R1—hematologic cancer	1.54e-05	0.000873	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—ASNS—hematologic cancer	1.53e-05	0.000873	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—B3GAT1—hematologic cancer	1.53e-05	0.000873	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—DCK—hematologic cancer	1.53e-05	0.000873	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—HDC—hematologic cancer	1.45e-05	0.000827	CbGpPWpGaD
Abacavir—ADK—Metabolism—GSTP1—hematologic cancer	1.45e-05	0.000823	CbGpPWpGaD
Abacavir—ADH6—Metabolism—PIK3CB—hematologic cancer	1.42e-05	0.000806	CbGpPWpGaD
Abacavir—ADK—Metabolism—ABCB1—hematologic cancer	1.37e-05	0.000779	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—CDA—hematologic cancer	1.33e-05	0.000757	CbGpPWpGaD
Abacavir—ADK—Metabolism—NCOR1—hematologic cancer	1.33e-05	0.000757	CbGpPWpGaD
Abacavir—ADK—Metabolism—GSTM1—hematologic cancer	1.33e-05	0.000757	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—PC—hematologic cancer	1.28e-05	0.000728	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—GBA—hematologic cancer	1.24e-05	0.000703	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—SLC35B2—hematologic cancer	1.24e-05	0.000703	CbGpPWpGaD
Abacavir—ADH6—Metabolism—PTEN—hematologic cancer	1.23e-05	0.000697	CbGpPWpGaD
Abacavir—ADK—Metabolism—MTHFR—hematologic cancer	1.18e-05	0.000669	CbGpPWpGaD
Abacavir—ADH6—Metabolism—EP300—hematologic cancer	1.17e-05	0.000664	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—MTAP—hematologic cancer	1.13e-05	0.000643	CbGpPWpGaD
Abacavir—UGT1A1—NRF2 pathway—TGFB1—hematologic cancer	1.07e-05	0.000608	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—FHL2—hematologic cancer	1.01e-05	0.000573	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—AGRN—hematologic cancer	9.89e-06	0.000562	CbGpPWpGaD
Abacavir—ADK—Metabolism—PIK3CG—hematologic cancer	9.88e-06	0.000562	CbGpPWpGaD
Abacavir—Erythema multiforme—Epirubicin—hematologic cancer	9.84e-06	0.000127	CcSEcCtD
Abacavir—Anxiety—Prednisone—hematologic cancer	9.83e-06	0.000127	CcSEcCtD
Abacavir—Alopecia—Methotrexate—hematologic cancer	9.83e-06	0.000127	CcSEcCtD
Abacavir—Vomiting—Gemcitabine—hematologic cancer	9.82e-06	0.000127	CcSEcCtD
Abacavir—Insomnia—Betamethasone—hematologic cancer	9.82e-06	0.000127	CcSEcCtD
Abacavir—Insomnia—Dexamethasone—hematologic cancer	9.82e-06	0.000127	CcSEcCtD
Abacavir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	9.79e-06	0.000126	CcSEcCtD
Abacavir—Paraesthesia—Betamethasone—hematologic cancer	9.75e-06	0.000126	CcSEcCtD
Abacavir—Paraesthesia—Dexamethasone—hematologic cancer	9.75e-06	0.000126	CcSEcCtD
Abacavir—Discomfort—Prednisone—hematologic cancer	9.74e-06	0.000126	CcSEcCtD
Abacavir—Rash—Gemcitabine—hematologic cancer	9.74e-06	0.000126	CcSEcCtD
Abacavir—Dermatitis—Gemcitabine—hematologic cancer	9.73e-06	0.000126	CcSEcCtD
Abacavir—Hypersensitivity—Etoposide—hematologic cancer	9.72e-06	0.000125	CcSEcCtD
Abacavir—Malnutrition—Methotrexate—hematologic cancer	9.68e-06	0.000125	CcSEcCtD
Abacavir—Headache—Gemcitabine—hematologic cancer	9.68e-06	0.000125	CcSEcCtD
Abacavir—Nausea—Vincristine—hematologic cancer	9.67e-06	0.000125	CcSEcCtD
Abacavir—Hepatitis—Doxorubicin—hematologic cancer	9.63e-06	0.000124	CcSEcCtD
Abacavir—Hypersensitivity—Prednisolone—hematologic cancer	9.58e-06	0.000124	CcSEcCtD
Abacavir—Pharyngitis—Doxorubicin—hematologic cancer	9.56e-06	0.000123	CcSEcCtD
Abacavir—Urticaria—Triamcinolone—hematologic cancer	9.5e-06	0.000123	CcSEcCtD
Abacavir—Asthenia—Etoposide—hematologic cancer	9.46e-06	0.000122	CcSEcCtD
Abacavir—Connective tissue disorder—Doxorubicin—hematologic cancer	9.46e-06	0.000122	CcSEcCtD
Abacavir—Body temperature increased—Triamcinolone—hematologic cancer	9.46e-06	0.000122	CcSEcCtD
Abacavir—Anaphylactic shock—Prednisone—hematologic cancer	9.45e-06	0.000122	CcSEcCtD
Abacavir—Oedema—Prednisone—hematologic cancer	9.45e-06	0.000122	CcSEcCtD
Abacavir—Decreased appetite—Dexamethasone—hematologic cancer	9.44e-06	0.000122	CcSEcCtD
Abacavir—Decreased appetite—Betamethasone—hematologic cancer	9.44e-06	0.000122	CcSEcCtD
Abacavir—Nausea—Irinotecan—hematologic cancer	9.42e-06	0.000122	CcSEcCtD
Abacavir—Nausea—Mitoxantrone—hematologic cancer	9.42e-06	0.000122	CcSEcCtD
Abacavir—Immune system disorder—Epirubicin—hematologic cancer	9.4e-06	0.000121	CcSEcCtD
Abacavir—Infection—Prednisone—hematologic cancer	9.39e-06	0.000121	CcSEcCtD
Abacavir—UGT1A1—Metabolism—HMMR—hematologic cancer	9.38e-06	0.000533	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—IDH2—hematologic cancer	9.38e-06	0.000533	CbGpPWpGaD
Abacavir—Gastrointestinal disorder—Dexamethasone—hematologic cancer	9.37e-06	0.000121	CcSEcCtD
Abacavir—Gastrointestinal disorder—Betamethasone—hematologic cancer	9.37e-06	0.000121	CcSEcCtD
Abacavir—Fatigue—Dexamethasone—hematologic cancer	9.36e-06	0.000121	CcSEcCtD
Abacavir—Fatigue—Betamethasone—hematologic cancer	9.36e-06	0.000121	CcSEcCtD
Abacavir—Chills—Epirubicin—hematologic cancer	9.34e-06	0.000121	CcSEcCtD
Abacavir—Pruritus—Etoposide—hematologic cancer	9.33e-06	0.00012	CcSEcCtD
Abacavir—Pain—Betamethasone—hematologic cancer	9.28e-06	0.00012	CcSEcCtD
Abacavir—Pain—Dexamethasone—hematologic cancer	9.28e-06	0.00012	CcSEcCtD
Abacavir—Nervous system disorder—Prednisone—hematologic cancer	9.27e-06	0.00012	CcSEcCtD
Abacavir—Alopecia—Epirubicin—hematologic cancer	9.2e-06	0.000119	CcSEcCtD
Abacavir—Skin disorder—Prednisone—hematologic cancer	9.18e-06	0.000119	CcSEcCtD
Abacavir—Nausea—Gemcitabine—hematologic cancer	9.17e-06	0.000118	CcSEcCtD
Abacavir—ADK—Metabolism—CREBBP—hematologic cancer	9.16e-06	0.000521	CbGpPWpGaD
Abacavir—Vomiting—Cisplatin—hematologic cancer	9.15e-06	0.000118	CcSEcCtD
Abacavir—Erythema multiforme—Doxorubicin—hematologic cancer	9.1e-06	0.000118	CcSEcCtD
Abacavir—Rash—Cisplatin—hematologic cancer	9.08e-06	0.000117	CcSEcCtD
Abacavir—Dermatitis—Cisplatin—hematologic cancer	9.07e-06	0.000117	CcSEcCtD
Abacavir—Malnutrition—Epirubicin—hematologic cancer	9.06e-06	0.000117	CcSEcCtD
Abacavir—Diarrhoea—Etoposide—hematologic cancer	9.02e-06	0.000116	CcSEcCtD
Abacavir—Anorexia—Prednisone—hematologic cancer	9.01e-06	0.000116	CcSEcCtD
Abacavir—Ill-defined disorder—Methotrexate—hematologic cancer	8.98e-06	0.000116	CcSEcCtD
Abacavir—Anaemia—Methotrexate—hematologic cancer	8.95e-06	0.000115	CcSEcCtD
Abacavir—Feeling abnormal—Dexamethasone—hematologic cancer	8.94e-06	0.000115	CcSEcCtD
Abacavir—Feeling abnormal—Betamethasone—hematologic cancer	8.94e-06	0.000115	CcSEcCtD
Abacavir—Gastrointestinal pain—Betamethasone—hematologic cancer	8.88e-06	0.000115	CcSEcCtD
Abacavir—Gastrointestinal pain—Dexamethasone—hematologic cancer	8.88e-06	0.000115	CcSEcCtD
Abacavir—UGT1A1—Metabolism—ARNTL—hematologic cancer	8.82e-06	0.000501	CbGpPWpGaD
Abacavir—Hypersensitivity—Triamcinolone—hematologic cancer	8.81e-06	0.000114	CcSEcCtD
Abacavir—Malaise—Methotrexate—hematologic cancer	8.73e-06	0.000113	CcSEcCtD
Abacavir—Dizziness—Etoposide—hematologic cancer	8.72e-06	0.000113	CcSEcCtD
Abacavir—Immune system disorder—Doxorubicin—hematologic cancer	8.7e-06	0.000112	CcSEcCtD
Abacavir—Vertigo—Methotrexate—hematologic cancer	8.7e-06	0.000112	CcSEcCtD
Abacavir—ADK—Metabolism—PIK3CD—hematologic cancer	8.69e-06	0.000494	CbGpPWpGaD
Abacavir—Leukopenia—Methotrexate—hematologic cancer	8.66e-06	0.000112	CcSEcCtD
Abacavir—ADH6—Metabolism—PIK3CA—hematologic cancer	8.64e-06	0.000491	CbGpPWpGaD
Abacavir—Chills—Doxorubicin—hematologic cancer	8.64e-06	0.000112	CcSEcCtD
Abacavir—Urticaria—Betamethasone—hematologic cancer	8.62e-06	0.000111	CcSEcCtD
Abacavir—Urticaria—Dexamethasone—hematologic cancer	8.62e-06	0.000111	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Prednisone—hematologic cancer	8.61e-06	0.000111	CcSEcCtD
Abacavir—Dizziness—Prednisolone—hematologic cancer	8.6e-06	0.000111	CcSEcCtD
Abacavir—Asthenia—Triamcinolone—hematologic cancer	8.58e-06	0.000111	CcSEcCtD
Abacavir—Body temperature increased—Betamethasone—hematologic cancer	8.58e-06	0.000111	CcSEcCtD
Abacavir—Body temperature increased—Dexamethasone—hematologic cancer	8.58e-06	0.000111	CcSEcCtD
Abacavir—Abdominal pain—Dexamethasone—hematologic cancer	8.58e-06	0.000111	CcSEcCtD
Abacavir—Abdominal pain—Betamethasone—hematologic cancer	8.58e-06	0.000111	CcSEcCtD
Abacavir—UGT1A1—Metabolism—CA9—hematologic cancer	8.58e-06	0.000488	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—ACP5—hematologic cancer	8.58e-06	0.000488	CbGpPWpGaD
Abacavir—ADK—Metabolism—ALB—hematologic cancer	8.58e-06	0.000488	CbGpPWpGaD
Abacavir—Nausea—Cisplatin—hematologic cancer	8.55e-06	0.00011	CcSEcCtD
Abacavir—Insomnia—Prednisone—hematologic cancer	8.55e-06	0.00011	CcSEcCtD
Abacavir—Alopecia—Doxorubicin—hematologic cancer	8.51e-06	0.00011	CcSEcCtD
Abacavir—Paraesthesia—Prednisone—hematologic cancer	8.49e-06	0.00011	CcSEcCtD
Abacavir—Pruritus—Triamcinolone—hematologic cancer	8.46e-06	0.000109	CcSEcCtD
Abacavir—UGT1A1—Metabolism—NCOR2—hematologic cancer	8.46e-06	0.000481	CbGpPWpGaD
Abacavir—Cough—Methotrexate—hematologic cancer	8.45e-06	0.000109	CcSEcCtD
Abacavir—Ill-defined disorder—Epirubicin—hematologic cancer	8.41e-06	0.000108	CcSEcCtD
Abacavir—Convulsion—Methotrexate—hematologic cancer	8.39e-06	0.000108	CcSEcCtD
Abacavir—Vomiting—Etoposide—hematologic cancer	8.39e-06	0.000108	CcSEcCtD
Abacavir—Malnutrition—Doxorubicin—hematologic cancer	8.38e-06	0.000108	CcSEcCtD
Abacavir—Anaemia—Epirubicin—hematologic cancer	8.37e-06	0.000108	CcSEcCtD
Abacavir—Rash—Etoposide—hematologic cancer	8.32e-06	0.000107	CcSEcCtD
Abacavir—Dermatitis—Etoposide—hematologic cancer	8.31e-06	0.000107	CcSEcCtD
Abacavir—Headache—Etoposide—hematologic cancer	8.26e-06	0.000107	CcSEcCtD
Abacavir—Myalgia—Methotrexate—hematologic cancer	8.24e-06	0.000106	CcSEcCtD
Abacavir—Arthralgia—Methotrexate—hematologic cancer	8.24e-06	0.000106	CcSEcCtD
Abacavir—Decreased appetite—Prednisone—hematologic cancer	8.22e-06	0.000106	CcSEcCtD
Abacavir—ADK—Metabolism—PIK3R1—hematologic cancer	8.2e-06	0.000466	CbGpPWpGaD
Abacavir—Rash—Prednisolone—hematologic cancer	8.2e-06	0.000106	CcSEcCtD
Abacavir—Dermatitis—Prednisolone—hematologic cancer	8.19e-06	0.000106	CcSEcCtD
Abacavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	8.18e-06	0.000106	CcSEcCtD
Abacavir—Malaise—Epirubicin—hematologic cancer	8.17e-06	0.000105	CcSEcCtD
Abacavir—Fatigue—Prednisone—hematologic cancer	8.15e-06	0.000105	CcSEcCtD
Abacavir—Headache—Prednisolone—hematologic cancer	8.15e-06	0.000105	CcSEcCtD
Abacavir—Discomfort—Methotrexate—hematologic cancer	8.14e-06	0.000105	CcSEcCtD
Abacavir—Vertigo—Epirubicin—hematologic cancer	8.14e-06	0.000105	CcSEcCtD
Abacavir—Leukopenia—Epirubicin—hematologic cancer	8.11e-06	0.000105	CcSEcCtD
Abacavir—UGT1A1—Metabolism—IDH1—hematologic cancer	8.06e-06	0.000458	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—ABCC3—hematologic cancer	7.97e-06	0.000453	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—TXN—hematologic cancer	7.97e-06	0.000453	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—GSTO1—hematologic cancer	7.97e-06	0.000453	CbGpPWpGaD
Abacavir—Dizziness—Triamcinolone—hematologic cancer	7.91e-06	0.000102	CcSEcCtD
Abacavir—Cough—Epirubicin—hematologic cancer	7.9e-06	0.000102	CcSEcCtD
Abacavir—Anaphylactic shock—Methotrexate—hematologic cancer	7.9e-06	0.000102	CcSEcCtD
Abacavir—Convulsion—Epirubicin—hematologic cancer	7.85e-06	0.000101	CcSEcCtD
Abacavir—Infection—Methotrexate—hematologic cancer	7.85e-06	0.000101	CcSEcCtD
Abacavir—Nausea—Etoposide—hematologic cancer	7.83e-06	0.000101	CcSEcCtD
Abacavir—UGT1A1—Metabolism—SPHK1—hematologic cancer	7.8e-06	0.000444	CbGpPWpGaD
Abacavir—Feeling abnormal—Prednisone—hematologic cancer	7.79e-06	0.000101	CcSEcCtD
Abacavir—Asthenia—Dexamethasone—hematologic cancer	7.79e-06	0.000101	CcSEcCtD
Abacavir—Asthenia—Betamethasone—hematologic cancer	7.79e-06	0.000101	CcSEcCtD
Abacavir—Ill-defined disorder—Doxorubicin—hematologic cancer	7.78e-06	0.0001	CcSEcCtD
Abacavir—Nervous system disorder—Methotrexate—hematologic cancer	7.75e-06	0.0001	CcSEcCtD
Abacavir—Anaemia—Doxorubicin—hematologic cancer	7.75e-06	0.0001	CcSEcCtD
Abacavir—Thrombocytopenia—Methotrexate—hematologic cancer	7.74e-06	9.98e-05	CcSEcCtD
Abacavir—Gastrointestinal pain—Prednisone—hematologic cancer	7.73e-06	9.98e-05	CcSEcCtD
Abacavir—Nausea—Prednisolone—hematologic cancer	7.73e-06	9.97e-05	CcSEcCtD
Abacavir—Myalgia—Epirubicin—hematologic cancer	7.71e-06	9.95e-05	CcSEcCtD
Abacavir—Arthralgia—Epirubicin—hematologic cancer	7.71e-06	9.95e-05	CcSEcCtD
Abacavir—Anxiety—Epirubicin—hematologic cancer	7.69e-06	9.92e-05	CcSEcCtD
Abacavir—Pruritus—Betamethasone—hematologic cancer	7.68e-06	9.91e-05	CcSEcCtD
Abacavir—Pruritus—Dexamethasone—hematologic cancer	7.68e-06	9.91e-05	CcSEcCtD
Abacavir—Skin disorder—Methotrexate—hematologic cancer	7.67e-06	9.9e-05	CcSEcCtD
Abacavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	7.66e-06	9.89e-05	CcSEcCtD
Abacavir—Discomfort—Epirubicin—hematologic cancer	7.62e-06	9.84e-05	CcSEcCtD
Abacavir—Vomiting—Triamcinolone—hematologic cancer	7.61e-06	9.82e-05	CcSEcCtD
Abacavir—ADK—Metabolism—PIK3CB—hematologic cancer	7.57e-06	0.00043	CbGpPWpGaD
Abacavir—Malaise—Doxorubicin—hematologic cancer	7.56e-06	9.76e-05	CcSEcCtD
Abacavir—Rash—Triamcinolone—hematologic cancer	7.54e-06	9.74e-05	CcSEcCtD
Abacavir—Dermatitis—Triamcinolone—hematologic cancer	7.54e-06	9.73e-05	CcSEcCtD
Abacavir—Vertigo—Doxorubicin—hematologic cancer	7.53e-06	9.72e-05	CcSEcCtD
Abacavir—Anorexia—Methotrexate—hematologic cancer	7.53e-06	9.72e-05	CcSEcCtD
Abacavir—Urticaria—Prednisone—hematologic cancer	7.51e-06	9.69e-05	CcSEcCtD
Abacavir—Leukopenia—Doxorubicin—hematologic cancer	7.5e-06	9.68e-05	CcSEcCtD
Abacavir—Headache—Triamcinolone—hematologic cancer	7.49e-06	9.67e-05	CcSEcCtD
Abacavir—Body temperature increased—Prednisone—hematologic cancer	7.47e-06	9.65e-05	CcSEcCtD
Abacavir—Abdominal pain—Prednisone—hematologic cancer	7.47e-06	9.65e-05	CcSEcCtD
Abacavir—Diarrhoea—Dexamethasone—hematologic cancer	7.43e-06	9.59e-05	CcSEcCtD
Abacavir—Diarrhoea—Betamethasone—hematologic cancer	7.43e-06	9.59e-05	CcSEcCtD
Abacavir—Anaphylactic shock—Epirubicin—hematologic cancer	7.39e-06	9.54e-05	CcSEcCtD
Abacavir—Oedema—Epirubicin—hematologic cancer	7.39e-06	9.54e-05	CcSEcCtD
Abacavir—Hypotension—Methotrexate—hematologic cancer	7.38e-06	9.53e-05	CcSEcCtD
Abacavir—Infection—Epirubicin—hematologic cancer	7.34e-06	9.48e-05	CcSEcCtD
Abacavir—Cough—Doxorubicin—hematologic cancer	7.31e-06	9.44e-05	CcSEcCtD
Abacavir—UGT1A1—Metabolism—SLC22A1—hematologic cancer	7.29e-06	0.000415	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—CRABP1—hematologic cancer	7.29e-06	0.000415	CbGpPWpGaD
Abacavir—Convulsion—Doxorubicin—hematologic cancer	7.26e-06	9.37e-05	CcSEcCtD
Abacavir—Nervous system disorder—Epirubicin—hematologic cancer	7.25e-06	9.36e-05	CcSEcCtD
Abacavir—Thrombocytopenia—Epirubicin—hematologic cancer	7.24e-06	9.34e-05	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Methotrexate—hematologic cancer	7.2e-06	9.29e-05	CcSEcCtD
Abacavir—Skin disorder—Epirubicin—hematologic cancer	7.18e-06	9.27e-05	CcSEcCtD
Abacavir—Dizziness—Dexamethasone—hematologic cancer	7.18e-06	9.27e-05	CcSEcCtD
Abacavir—Dizziness—Betamethasone—hematologic cancer	7.18e-06	9.27e-05	CcSEcCtD
Abacavir—Insomnia—Methotrexate—hematologic cancer	7.15e-06	9.22e-05	CcSEcCtD
Abacavir—Arthralgia—Doxorubicin—hematologic cancer	7.14e-06	9.21e-05	CcSEcCtD
Abacavir—Myalgia—Doxorubicin—hematologic cancer	7.14e-06	9.21e-05	CcSEcCtD
Abacavir—Anxiety—Doxorubicin—hematologic cancer	7.11e-06	9.18e-05	CcSEcCtD
Abacavir—Nausea—Triamcinolone—hematologic cancer	7.11e-06	9.17e-05	CcSEcCtD
Abacavir—UGT1A1—Metabolism—ALOX5—hematologic cancer	7.11e-06	0.000404	CbGpPWpGaD
Abacavir—Paraesthesia—Methotrexate—hematologic cancer	7.09e-06	9.16e-05	CcSEcCtD
Abacavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	7.09e-06	9.15e-05	CcSEcCtD
Abacavir—ADH6—Metabolism—AKT1—hematologic cancer	7.06e-06	0.000401	CbGpPWpGaD
Abacavir—Discomfort—Doxorubicin—hematologic cancer	7.05e-06	9.1e-05	CcSEcCtD
Abacavir—Anorexia—Epirubicin—hematologic cancer	7.05e-06	9.1e-05	CcSEcCtD
Abacavir—Dyspnoea—Methotrexate—hematologic cancer	7.04e-06	9.09e-05	CcSEcCtD
Abacavir—Hypersensitivity—Prednisone—hematologic cancer	6.96e-06	8.99e-05	CcSEcCtD
Abacavir—Hypotension—Epirubicin—hematologic cancer	6.91e-06	8.92e-05	CcSEcCtD
Abacavir—Vomiting—Betamethasone—hematologic cancer	6.9e-06	8.91e-05	CcSEcCtD
Abacavir—Vomiting—Dexamethasone—hematologic cancer	6.9e-06	8.91e-05	CcSEcCtD
Abacavir—UGT1A1—Metabolism—NUP98—hematologic cancer	6.88e-06	0.000391	CbGpPWpGaD
Abacavir—Decreased appetite—Methotrexate—hematologic cancer	6.87e-06	8.86e-05	CcSEcCtD
Abacavir—Rash—Dexamethasone—hematologic cancer	6.84e-06	8.83e-05	CcSEcCtD
Abacavir—Rash—Betamethasone—hematologic cancer	6.84e-06	8.83e-05	CcSEcCtD
Abacavir—Anaphylactic shock—Doxorubicin—hematologic cancer	6.84e-06	8.83e-05	CcSEcCtD
Abacavir—Oedema—Doxorubicin—hematologic cancer	6.84e-06	8.83e-05	CcSEcCtD
Abacavir—Dermatitis—Betamethasone—hematologic cancer	6.84e-06	8.83e-05	CcSEcCtD
Abacavir—Dermatitis—Dexamethasone—hematologic cancer	6.84e-06	8.83e-05	CcSEcCtD
Abacavir—Gastrointestinal disorder—Methotrexate—hematologic cancer	6.82e-06	8.8e-05	CcSEcCtD
Abacavir—Fatigue—Methotrexate—hematologic cancer	6.81e-06	8.79e-05	CcSEcCtD
Abacavir—Headache—Dexamethasone—hematologic cancer	6.8e-06	8.78e-05	CcSEcCtD
Abacavir—Headache—Betamethasone—hematologic cancer	6.8e-06	8.78e-05	CcSEcCtD
Abacavir—Infection—Doxorubicin—hematologic cancer	6.8e-06	8.77e-05	CcSEcCtD
Abacavir—Asthenia—Prednisone—hematologic cancer	6.78e-06	8.75e-05	CcSEcCtD
Abacavir—Pain—Methotrexate—hematologic cancer	6.76e-06	8.72e-05	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Epirubicin—hematologic cancer	6.74e-06	8.69e-05	CcSEcCtD
Abacavir—Nervous system disorder—Doxorubicin—hematologic cancer	6.71e-06	8.66e-05	CcSEcCtD
Abacavir—Thrombocytopenia—Doxorubicin—hematologic cancer	6.7e-06	8.65e-05	CcSEcCtD
Abacavir—Pruritus—Prednisone—hematologic cancer	6.69e-06	8.63e-05	CcSEcCtD
Abacavir—Insomnia—Epirubicin—hematologic cancer	6.69e-06	8.63e-05	CcSEcCtD
Abacavir—UGT1A1—Metabolism—ADCY7—hematologic cancer	6.68e-06	0.00038	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—NCOA3—hematologic cancer	6.68e-06	0.00038	CbGpPWpGaD
Abacavir—Skin disorder—Doxorubicin—hematologic cancer	6.64e-06	8.58e-05	CcSEcCtD
Abacavir—Paraesthesia—Epirubicin—hematologic cancer	6.64e-06	8.57e-05	CcSEcCtD
Abacavir—UGT1A1—Metabolism—NUP214—hematologic cancer	6.63e-06	0.000377	CbGpPWpGaD
Abacavir—Dyspnoea—Epirubicin—hematologic cancer	6.59e-06	8.51e-05	CcSEcCtD
Abacavir—ADK—Metabolism—PTEN—hematologic cancer	6.54e-06	0.000372	CbGpPWpGaD
Abacavir—Anorexia—Doxorubicin—hematologic cancer	6.52e-06	8.42e-05	CcSEcCtD
Abacavir—Feeling abnormal—Methotrexate—hematologic cancer	6.51e-06	8.4e-05	CcSEcCtD
Abacavir—UGT1A1—Metabolism—MTR—hematologic cancer	6.5e-06	0.000369	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—ABCG2—hematologic cancer	6.5e-06	0.000369	CbGpPWpGaD
Abacavir—Diarrhoea—Prednisone—hematologic cancer	6.47e-06	8.35e-05	CcSEcCtD
Abacavir—Gastrointestinal pain—Methotrexate—hematologic cancer	6.46e-06	8.34e-05	CcSEcCtD
Abacavir—Nausea—Betamethasone—hematologic cancer	6.45e-06	8.32e-05	CcSEcCtD
Abacavir—Nausea—Dexamethasone—hematologic cancer	6.45e-06	8.32e-05	CcSEcCtD
Abacavir—Decreased appetite—Epirubicin—hematologic cancer	6.43e-06	8.3e-05	CcSEcCtD
Abacavir—Hypotension—Doxorubicin—hematologic cancer	6.39e-06	8.25e-05	CcSEcCtD
Abacavir—Gastrointestinal disorder—Epirubicin—hematologic cancer	6.38e-06	8.24e-05	CcSEcCtD
Abacavir—Fatigue—Epirubicin—hematologic cancer	6.37e-06	8.23e-05	CcSEcCtD
Abacavir—UGT1A1—Metabolism—ENO2—hematologic cancer	6.37e-06	0.000362	CbGpPWpGaD
Abacavir—Pain—Epirubicin—hematologic cancer	6.32e-06	8.16e-05	CcSEcCtD
Abacavir—Urticaria—Methotrexate—hematologic cancer	6.28e-06	8.1e-05	CcSEcCtD
Abacavir—Dizziness—Prednisone—hematologic cancer	6.25e-06	8.07e-05	CcSEcCtD
Abacavir—Body temperature increased—Methotrexate—hematologic cancer	6.25e-06	8.06e-05	CcSEcCtD
Abacavir—Abdominal pain—Methotrexate—hematologic cancer	6.25e-06	8.06e-05	CcSEcCtD
Abacavir—ADK—Metabolism—EP300—hematologic cancer	6.24e-06	0.000355	CbGpPWpGaD
Abacavir—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	6.23e-06	8.04e-05	CcSEcCtD
Abacavir—Insomnia—Doxorubicin—hematologic cancer	6.19e-06	7.99e-05	CcSEcCtD
Abacavir—UGT1A1—Metabolism—GSTT1—hematologic cancer	6.18e-06	0.000351	CbGpPWpGaD
Abacavir—Paraesthesia—Doxorubicin—hematologic cancer	6.14e-06	7.93e-05	CcSEcCtD
Abacavir—Dyspnoea—Doxorubicin—hematologic cancer	6.1e-06	7.87e-05	CcSEcCtD
Abacavir—Feeling abnormal—Epirubicin—hematologic cancer	6.09e-06	7.86e-05	CcSEcCtD
Abacavir—Gastrointestinal pain—Epirubicin—hematologic cancer	6.05e-06	7.8e-05	CcSEcCtD
Abacavir—UGT1A1—Metabolism—SDC1—hematologic cancer	6.04e-06	0.000343	CbGpPWpGaD
Abacavir—Vomiting—Prednisone—hematologic cancer	6.01e-06	7.76e-05	CcSEcCtD
Abacavir—Rash—Prednisone—hematologic cancer	5.96e-06	7.69e-05	CcSEcCtD
Abacavir—Dermatitis—Prednisone—hematologic cancer	5.95e-06	7.69e-05	CcSEcCtD
Abacavir—Decreased appetite—Doxorubicin—hematologic cancer	5.95e-06	7.68e-05	CcSEcCtD
Abacavir—Headache—Prednisone—hematologic cancer	5.92e-06	7.64e-05	CcSEcCtD
Abacavir—Gastrointestinal disorder—Doxorubicin—hematologic cancer	5.91e-06	7.62e-05	CcSEcCtD
Abacavir—Fatigue—Doxorubicin—hematologic cancer	5.9e-06	7.61e-05	CcSEcCtD
Abacavir—Urticaria—Epirubicin—hematologic cancer	5.87e-06	7.58e-05	CcSEcCtD
Abacavir—Pain—Doxorubicin—hematologic cancer	5.85e-06	7.55e-05	CcSEcCtD
Abacavir—Body temperature increased—Epirubicin—hematologic cancer	5.84e-06	7.54e-05	CcSEcCtD
Abacavir—Abdominal pain—Epirubicin—hematologic cancer	5.84e-06	7.54e-05	CcSEcCtD
Abacavir—Hypersensitivity—Methotrexate—hematologic cancer	5.82e-06	7.51e-05	CcSEcCtD
Abacavir—Asthenia—Methotrexate—hematologic cancer	5.67e-06	7.32e-05	CcSEcCtD
Abacavir—Feeling abnormal—Doxorubicin—hematologic cancer	5.64e-06	7.28e-05	CcSEcCtD
Abacavir—Nausea—Prednisone—hematologic cancer	5.61e-06	7.25e-05	CcSEcCtD
Abacavir—Gastrointestinal pain—Doxorubicin—hematologic cancer	5.59e-06	7.22e-05	CcSEcCtD
Abacavir—Pruritus—Methotrexate—hematologic cancer	5.59e-06	7.21e-05	CcSEcCtD
Abacavir—Hypersensitivity—Epirubicin—hematologic cancer	5.45e-06	7.03e-05	CcSEcCtD
Abacavir—Urticaria—Doxorubicin—hematologic cancer	5.43e-06	7.01e-05	CcSEcCtD
Abacavir—Abdominal pain—Doxorubicin—hematologic cancer	5.41e-06	6.98e-05	CcSEcCtD
Abacavir—Body temperature increased—Doxorubicin—hematologic cancer	5.41e-06	6.98e-05	CcSEcCtD
Abacavir—Diarrhoea—Methotrexate—hematologic cancer	5.41e-06	6.98e-05	CcSEcCtD
Abacavir—Asthenia—Epirubicin—hematologic cancer	5.3e-06	6.85e-05	CcSEcCtD
Abacavir—Pruritus—Epirubicin—hematologic cancer	5.23e-06	6.75e-05	CcSEcCtD
Abacavir—Dizziness—Methotrexate—hematologic cancer	5.22e-06	6.74e-05	CcSEcCtD
Abacavir—UGT1A1—Metabolism—CD44—hematologic cancer	5.14e-06	0.000292	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—NQO1—hematologic cancer	5.14e-06	0.000292	CbGpPWpGaD
Abacavir—Diarrhoea—Epirubicin—hematologic cancer	5.06e-06	6.53e-05	CcSEcCtD
Abacavir—Hypersensitivity—Doxorubicin—hematologic cancer	5.04e-06	6.51e-05	CcSEcCtD
Abacavir—Vomiting—Methotrexate—hematologic cancer	5.02e-06	6.48e-05	CcSEcCtD
Abacavir—Rash—Methotrexate—hematologic cancer	4.98e-06	6.43e-05	CcSEcCtD
Abacavir—Dermatitis—Methotrexate—hematologic cancer	4.98e-06	6.42e-05	CcSEcCtD
Abacavir—Headache—Methotrexate—hematologic cancer	4.95e-06	6.39e-05	CcSEcCtD
Abacavir—Asthenia—Doxorubicin—hematologic cancer	4.91e-06	6.34e-05	CcSEcCtD
Abacavir—Dizziness—Epirubicin—hematologic cancer	4.89e-06	6.31e-05	CcSEcCtD
Abacavir—UGT1A1—Metabolism—CYCS—hematologic cancer	4.86e-06	0.000276	CbGpPWpGaD
Abacavir—Pruritus—Doxorubicin—hematologic cancer	4.84e-06	6.25e-05	CcSEcCtD
Abacavir—UGT1A1—Metabolism—HSP90AA1—hematologic cancer	4.83e-06	0.000275	CbGpPWpGaD
Abacavir—Vomiting—Epirubicin—hematologic cancer	4.7e-06	6.07e-05	CcSEcCtD
Abacavir—Nausea—Methotrexate—hematologic cancer	4.69e-06	6.06e-05	CcSEcCtD
Abacavir—Diarrhoea—Doxorubicin—hematologic cancer	4.68e-06	6.04e-05	CcSEcCtD
Abacavir—Rash—Epirubicin—hematologic cancer	4.66e-06	6.02e-05	CcSEcCtD
Abacavir—Dermatitis—Epirubicin—hematologic cancer	4.66e-06	6.01e-05	CcSEcCtD
Abacavir—Headache—Epirubicin—hematologic cancer	4.63e-06	5.98e-05	CcSEcCtD
Abacavir—ADK—Metabolism—PIK3CA—hematologic cancer	4.62e-06	0.000262	CbGpPWpGaD
Abacavir—Dizziness—Doxorubicin—hematologic cancer	4.52e-06	5.84e-05	CcSEcCtD
Abacavir—Nausea—Epirubicin—hematologic cancer	4.39e-06	5.67e-05	CcSEcCtD
Abacavir—Vomiting—Doxorubicin—hematologic cancer	4.35e-06	5.61e-05	CcSEcCtD
Abacavir—Rash—Doxorubicin—hematologic cancer	4.31e-06	5.57e-05	CcSEcCtD
Abacavir—Dermatitis—Doxorubicin—hematologic cancer	4.31e-06	5.56e-05	CcSEcCtD
Abacavir—Headache—Doxorubicin—hematologic cancer	4.29e-06	5.53e-05	CcSEcCtD
Abacavir—UGT1A1—Metabolism—GSTP1—hematologic cancer	4.28e-06	0.000244	CbGpPWpGaD
Abacavir—Nausea—Doxorubicin—hematologic cancer	4.06e-06	5.24e-05	CcSEcCtD
Abacavir—UGT1A1—Metabolism—ABCB1—hematologic cancer	4.06e-06	0.000231	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—GSTM1—hematologic cancer	3.94e-06	0.000224	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—NCOR1—hematologic cancer	3.94e-06	0.000224	CbGpPWpGaD
Abacavir—ADK—Metabolism—AKT1—hematologic cancer	3.77e-06	0.000214	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—MTHFR—hematologic cancer	3.48e-06	0.000198	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—PIK3CG—hematologic cancer	2.92e-06	0.000166	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—CREBBP—hematologic cancer	2.71e-06	0.000154	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—PIK3CD—hematologic cancer	2.57e-06	0.000146	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—ALB—hematologic cancer	2.54e-06	0.000144	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—PIK3R1—hematologic cancer	2.43e-06	0.000138	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—PIK3CB—hematologic cancer	2.24e-06	0.000127	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—PTEN—hematologic cancer	1.94e-06	0.00011	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—EP300—hematologic cancer	1.85e-06	0.000105	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—PIK3CA—hematologic cancer	1.37e-06	7.76e-05	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—AKT1—hematologic cancer	1.12e-06	6.34e-05	CbGpPWpGaD
